Bruin Cll-313: A Phase 3 Open-Label, Randomized Study Of Pirtobrutinib Vs Bendamustine+Rituximab In Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial In Progress)
Pirtobrutinib;Bendamustine;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Bruin Cll-313: A Phase 3 Open-Label, Randomized Study Of Pirtobrutinib Vs Bendamustine+Rituximab In Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial In Progress) ### Output: Pirtobrutinib;Bendamustine;Rituximab